Wythenshawe patient takes part in national project to understand changes to radiotherapy treatments during COVID-19
A lung cancer patient at Wythenshawe Hospital has taken part in a national project led by Manchester researchers, investigating changes in radiotherapy treatments during COVID-19.
Noreen Ingham, 76, from Gatley, was diagnosed and cared for at Wythenshawe Hospital, part of Manchester University NHS Foundation Trust (MFT), before being referred to The Christie for radiotherapy.
The project, called COVID-RT Lung, led by clinicians at The Christie, aims to build a national database assessing radiotherapy treatments for lung cancer patients during the pandemic, and how this has affected patient outcomes.
Information on Noreen’s care will be used as part of the project, alongside those from 2000 other patients. She said:
“I was a smoker up until the age of 50, until my dad died from lung cancer. It really affected me, and three years later I managed to give up smoking for good.
I’m always happy to help doctors and have taken part in research studies in the past. My lung cancer was picked up during a study for ex-smokers. The doctors then did various tests and I was sent for a scan of my lungs where they found a mark which was lung cancer.
“My treatment was initially meant to be surgery to remove the tumour at Wythenshawe Hospital. This was right at the start of lockdown. The team said I would need to recover in intensive care, where many COVID patients were being cared for. I was at higher risk due to other health conditions. After discussing my options with them, we decided radiotherapy at The Christie would be just as good for treating the type of tumour I had and mean I wouldn’t need to recover in hospital.”